Arvind Chhabra received his Ph.D. degree from the Central Drug Research Institute (CDRI), Lucknow, India, in 2001. Chhabra serves as an Assistant Professor at the Department of Medicine, the University of Connecticut Health Center, Farmington, Conn, USA, since 2008. His research is focused on developing an effective cancer immunotherapy against human melanoma. The generation of a protective antitumor immune response faces many inherent constraints, such as, an extremely low frequency of antitumor T-cell precursors in most cancer patients and the lack of an effective method to engage CD4 T cells in tumor immunity, especially in an antigen specific manner. He published more than eighteen research manuscripts, and his work has received several awards at international cancer immunotherapy meetings. Chhabra aims at studying the T-cell receptor triggered signal transduction mechanisms regulating the generation of effector function and activation-induced cell death (AICD) in human tumor antigen specific primary T cells. Chhabra's experience includes cellular immunology, cancer immunotherapy, and the differentiation of IPS cells into hematopoietic lineage.
Biography Updated on 6 June 2012